找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistance to Targeted Therapies Against Adult Brain Cancers; Amanda Tivnan Book 2016 Springer International Publishing AG 2016 Brain canc

[復(fù)制鏈接]
樓主: 手或腳
31#
發(fā)表于 2025-3-26 22:42:59 | 只看該作者
32#
發(fā)表于 2025-3-27 04:36:45 | 只看該作者
33#
發(fā)表于 2025-3-27 06:14:35 | 只看該作者
34#
發(fā)表于 2025-3-27 10:39:05 | 只看該作者
35#
發(fā)表于 2025-3-27 15:45:37 | 只看該作者
The Blood-Brain Barrier in Glioblastoma: Pathology and Therapeutic Implications, associated with rapid and aggressive tumour growth with associated cerebral oedema. Central to the difficulty associated with treating GBM is the challenge of getting chemotherapeutic drugs to cross the blood-brain barrier (BBB). Although vasculature within and around a GBM becomes more permeable d
36#
發(fā)表于 2025-3-27 21:39:13 | 只看該作者
Resistance of Brain Tumours to Small-Molecule-Targeted Therapies: Lessons from Various Cancer Types resection or sequential or concurrent chemoradiotherapy with chemotherapy such as temozolomide. Despite improvements in these treatments, survival rate is less than 10 % 5 years after diagnosis, and there are limited second-line treatments available. Although recent improvements in understanding th
37#
發(fā)表于 2025-3-28 01:35:19 | 只看該作者
38#
發(fā)表于 2025-3-28 05:14:42 | 只看該作者
39#
發(fā)表于 2025-3-28 06:29:28 | 只看該作者
Imaging Targeted Therapy Response and Resistance in Glioblastoma, GBM, the disease still remains in desperate need of effective treatment options resulting in long-term improvements in overall patient survival. Molecularly targeted therapies, anti-angiogenic therapy and immunotherapy are promising avenues under investigation as future therapeutic options. Molecul
40#
發(fā)表于 2025-3-28 12:53:01 | 只看該作者
Drug Resistance in Malignant Meningiomas,e benign, approximately 5–15 % of meningiomas are non-benign. These tumors are histologically Grade II and III and have a propensity to be aggressive and occasionally metastasize. Multiple genetic abnormalities and epigenetic changes are involved in the formation and malignant transformation of meni
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 12:08
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
崇阳县| 花莲市| 永修县| 宁德市| 睢宁县| 泸州市| 新乐市| 抚远县| 芦溪县| 措美县| 汾阳市| 平陆县| 依安县| 阜城县| 定西市| 芜湖县| 台中市| 涟源市| 普宁市| 临猗县| 灵川县| 乌兰察布市| 刚察县| 射阳县| 澎湖县| 合肥市| 临泽县| 邹城市| 鞍山市| 湖南省| 石门县| 冀州市| 济南市| 乌恰县| 顺昌县| 永丰县| 西乡县| 金山区| 搜索| 葫芦岛市| 旬阳县|